PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
81.17
+0.39 (0.48%)
At close: Dec 20, 2024, 4:00 PM
81.21
+0.04 (0.05%)
After-hours: Dec 20, 2024, 4:29 PM EST
PROCEPT BioRobotics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for PROCEPT BioRobotics stock have an average target of 97.86, with a low estimate of 75 and a high estimate of 112. The average target predicts an increase of 20.56% from the current stock price of 81.17.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRCT stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 2 | 2 | 3 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 5 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $112 | Buy | Initiates | $112 | +37.98% | Dec 3, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $105 | Buy | Initiates | $105 | +29.36% | Dec 2, 2024 |
| Jefferies | Jefferies | Hold Initiates $95 | Hold | Initiates | $95 | +17.04% | Nov 14, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $95 → $105 | Strong Buy | Reiterates | $95 → $105 | +29.36% | Oct 30, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $75 | Buy | Reiterates | $75 | -7.60% | Oct 8, 2024 |
Financial Forecast
Revenue This Year
227.53M
from 136.19M
Increased by 67.07%
Revenue Next Year
320.00M
from 227.53M
Increased by 40.64%
EPS This Year
-1.77
from -2.24
EPS Next Year
-1.36
from -1.77
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 235.1M | 340.2M | 457.8M | |||
| Avg | 227.5M | 320.0M | 421.7M | |||
| Low | 218.1M | 289.0M | 355.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 72.6% | 49.5% | 43.1% | |||
| Avg | 67.1% | 40.6% | 31.8% | |||
| Low | 60.2% | 27.0% | 11.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.79 | -1.11 | -0.60 | |||
| Avg | -1.77 | -1.36 | -0.79 | |||
| Low | -1.71 | -1.49 | -1.09 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.